BRIGHT MINDS BIOSCIENCES INC. (DRUG): key financial figures for fiscal year 2024 (in CAD), standardized from XBRL/iXBRL filings by Hub-Equity:

Source: BRIGHT MINDS BIOSCIENCES INC. 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.